,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Acute myeloid leukaemia,2,17177624
1,22.1,Second primary malignancy,2,17177624
2,22.1,Osteonecrosis of jaw,6,17177624
0,22.1,Neutropenia,6,17177923
1,22.1,Off label use,6,17177923
2,22.1,Anaemia,6,17177923
3,22.1,Product use issue,6,17177923
0,22.1,Constipation,3,17177955
1,22.1,Weight decreased,3,17177955
2,22.1,Paranasal sinus discomfort,3,17177955
3,22.1,Pyrexia,3,17177955
4,22.1,Pain,3,17177955
5,22.1,Infusion related reaction,3,17177955
6,22.1,Incorrect dose administered,3,17177955
7,22.1,Nasopharyngitis,3,17177955
8,22.1,Fatigue,3,17177955
9,22.1,Haemorrhoids,3,17177955
10,22.1,Lymphoedema,3,17177955
11,22.1,Seizure,3,17177955
12,22.1,Weight increased,3,17177955
13,22.1,Brain neoplasm,3,17177955
14,22.1,Urinary tract disorder,3,17177955
15,22.1,Blood pressure decreased,3,17177955
16,22.1,Nausea,3,17177955
17,22.1,Tooth disorder,3,17177955
0,22.1,Drug resistance,6,17177963
1,22.1,EGFR gene mutation,6,17177963
0,22.1,Malignant neoplasm progression,6,17177993
0,22.1,Nausea,6,17177994
1,22.1,Treatment failure,6,17177994
2,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17177994
0,22.1,Hordeolum,1,17178037
1,22.1,Varicella zoster virus infection,1,17178037
0,22.1,Drug resistance,6,17178055
1,22.1,EGFR gene mutation,6,17178055
0,22.1,Therapy non-responder,5,17178115
0,22.1,Disease progression,6,17178120
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17178125
0,22.1,Retinitis,1,17178192
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17178220
1,22.1,Fingerprint loss,6,17178220
2,22.1,Condition aggravated,6,17178220
0,22.1,Rash,6,17178298
1,22.1,Decreased appetite,6,17178298
2,22.1,Peripheral swelling,6,17178298
3,22.1,Joint swelling,6,17178298
0,22.1,Ischaemic stroke,2,17178305
0,22.1,Blood creatinine increased,2,17178384
0,22.1,Ophthalmic herpes zoster,1,17178441
0,22.1,Loss of consciousness,1,17178519
1,22.1,Dementia,1,17178519
0,22.1,Abdominal pain upper,2,17178622
1,22.1,Vomiting,3,17178622
2,22.1,Cough,3,17178622
3,22.1,Blood sodium abnormal,3,17178622
4,22.1,Headache,3,17178622
5,22.1,Hypertension,1,17178622
6,22.1,Chills,1,17178622
7,22.1,Blood pressure increased,1,17178622
8,22.1,Fatigue,2,17178622
9,22.1,Thyroid hormones increased,3,17178622
10,22.1,Decreased appetite,2,17178622
11,22.1,Tumour marker increased,3,17178622
0,22.1,Intentional product use issue,6,17178705
1,22.1,Back pain,6,17178705
0,22.1,Pneumonia,6,17178714
0,22.1,Immobile,6,17178730
1,22.1,Cough,6,17178730
2,22.1,Rhinorrhoea,6,17178730
3,22.1,Asthenia,6,17178730
0,22.1,Hair colour changes,3,17178786
1,22.1,Alopecia,3,17178786
2,22.1,Hair texture abnormal,3,17178786
3,22.1,Hair disorder,3,17178786
0,22.1,Interstitial lung disease,4,17178828
1,22.1,Respiratory failure,6,17178828
0,22.1,Erythema,3,17178860
1,22.1,Ascites,6,17178860
2,22.1,Diarrhoea,2,17178860
3,22.1,Oral mucosal blistering,3,17178860
4,22.1,Decreased appetite,3,17178860
5,22.1,Peripheral swelling,3,17178860
6,22.1,Cough,2,17178860
7,22.1,Accident,3,17178860
8,22.1,Rash,3,17178860
9,22.1,Tongue blistering,3,17178860
10,22.1,Dyspnoea,3,17178860
11,22.1,Nausea,2,17178860
0,22.1,Death,5,17178862
0,22.1,Death,5,17178864
1,22.1,Off label use,6,17178864
2,22.1,Intentional product use issue,6,17178864
0,22.1,Toxicity to various agents,5,17178865
0,22.1,Toxicity to various agents,6,17178878
1,22.1,Death,5,17178878
0,22.1,Death,5,17178966
0,22.1,Loss of consciousness,1,17179006
1,22.1,Hypotension,1,17179006
2,22.1,Dyspnoea,1,17179006
3,22.1,Vomiting,1,17179006
4,22.1,Nausea,1,17179006
5,22.1,Chest pain,1,17179006
6,22.1,Hyperhidrosis,1,17179006
0,22.1,Meningioma,3,17179018
0,22.1,Product use in unapproved indication,6,17179051
1,22.1,Fall,3,17179051
0,22.1,Febrile neutropenia,2,17179059
0,22.1,Malignant neoplasm progression,5,17179114
1,22.1,Myasthenia gravis,2,17179114
0,22.1,Anaemia,3,17179130
1,22.1,Septic shock,1,17179130
2,22.1,Leukopenia,1,17179130
3,22.1,Thrombocytopenia,1,17179130
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,17179169
1,22.1,Ileus,2,17179169
0,22.1,Paraesthesia,2,17179173
1,22.1,Amenorrhoea,2,17179173
0,22.1,Pain,5,17179189
0,22.1,Nausea,3,17179190
1,22.1,Alanine aminotransferase increased,3,17179190
2,22.1,Nasopharyngitis,3,17179190
3,22.1,Pulmonary embolism,3,17179190
4,22.1,Alopecia,3,17179190
5,22.1,Anxiety,3,17179190
6,22.1,Fatigue,3,17179190
7,22.1,Mucosal inflammation,3,17179190
8,22.1,Breast cancer,3,17179190
9,22.1,Aspartate aminotransferase increased,3,17179190
10,22.1,Pyrexia,3,17179190
11,22.1,Headache,3,17179190
12,22.1,Insomnia,3,17179190
13,22.1,Malignant neoplasm progression,3,17179190
14,22.1,Oedema peripheral,3,17179190
15,22.1,Oral pain,3,17179190
16,22.1,Vomiting,3,17179190
0,22.1,Malaise,5,17179204
1,22.1,Lung disorder,5,17179204
0,22.1,Malignant neoplasm progression,6,17179277
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17179294
1,22.1,Diarrhoea,6,17179294
2,22.1,Pruritus,6,17179294
0,22.1,Pancytopenia,1,17179306
1,22.1,Urosepsis,1,17179306
2,22.1,Rhabdomyolysis,1,17179306
0,22.1,Disease progression,5,17179316
0,22.1,Death,5,17179318
1,22.1,Off label use,6,17179318
2,22.1,Intentional product use issue,6,17179318
0,22.1,Second primary malignancy,3,17179320
1,22.1,Acute myeloid leukaemia,3,17179320
0,22.1,Arteritis,1,17179331
0,22.1,General physical health deterioration,3,17179345
0,22.1,Interstitial lung disease,5,17179360
1,22.1,Delirium,3,17179360
2,22.1,Off label use,6,17179360
3,22.1,Cerebral infarction,3,17179360
4,22.1,Loss of consciousness,6,17179360
5,22.1,Enterocolitis,2,17179360
6,22.1,Pneumonia aspiration,5,17179360
7,22.1,Physical deconditioning,6,17179360
8,22.1,Hypoaesthesia,6,17179360
0,22.1,Abdominal pain,1,17179367
0,22.1,Bone marrow failure,5,17179373
1,22.1,Dehydration,6,17179373
0,22.1,Nausea,1,17179382
1,22.1,Hypophagia,1,17179382
0,22.1,Pulmonary embolism,5,17179385
1,22.1,Haematotoxicity,1,17179385
2,22.1,Acute cardiac event,5,17179385
0,22.1,Facial paralysis,6,17179408
0,22.1,Decubitus ulcer,1,17179467
0,22.1,Drug hypersensitivity,6,17179476
0,22.1,Urinary tract infection,1,17179515
1,22.1,Vomiting,1,17179515
2,22.1,Gait disturbance,3,17179515
3,22.1,Pyrexia,1,17179515
4,22.1,Asthenia,3,17179515
5,22.1,Pain,3,17179515
0,22.1,Acute kidney injury,1,17179521
0,22.1,Immune thrombocytopenic purpura,1,17179545
1,22.1,Rectal haemorrhage,6,17179545
0,22.1,Complication of device insertion,1,17179591
1,22.1,Muscle spasms,1,17179591
0,22.1,Pyrexia,2,17179707
1,22.1,C-reactive protein increased,2,17179707
0,22.1,Malignant neoplasm progression,5,17179815
0,22.1,Blood alkaline phosphatase increased,3,17179892
1,22.1,Hormone-refractory prostate cancer,3,17179892
2,22.1,Prostatic specific antigen increased,3,17179892
0,22.1,Neoplasm malignant,6,17179905
1,22.1,Off label use,3,17179905
2,22.1,Chest pain,6,17179905
0,22.1,Asthenia,2,17179915
1,22.1,Immunosuppression,2,17179915
2,22.1,Platelet count decreased,2,17179915
3,22.1,Protein total increased,2,17179915
4,22.1,Neoplasm progression,2,17179915
5,22.1,Meningoencephalitis herpetic,2,17179915
6,22.1,Headache,2,17179915
0,22.1,Disease progression,6,17179923
1,22.1,Proteinuria,1,17179923
0,22.1,Acute kidney injury,1,17179941
0,22.1,Product use in unapproved indication,6,17179944
1,22.1,Off label use,6,17179944
2,22.1,Amnesia,1,17179944
3,22.1,Hallucination,6,17179944
0,22.1,Renal impairment,6,17179977
0,22.1,Decreased appetite,1,17179978
1,22.1,Hypertension,2,17179978
2,22.1,Nausea,2,17179978
3,22.1,Diarrhoea,2,17179978
4,22.1,Palmar-plantar erythrodysaesthesia syndrome,2,17179978
0,22.1,Carpal tunnel syndrome,6,17180018
1,22.1,Neuropathy peripheral,6,17180018
2,22.1,Folate deficiency,6,17180018
3,22.1,Vitamin B12 deficiency,6,17180018
0,22.1,Death,5,17180089
0,22.1,Melaena,2,17180156
1,22.1,Immune thrombocytopenic purpura,1,17180156
2,22.1,Haemoglobin decreased,2,17180156
0,22.1,Potentiating drug interaction,1,17180181
1,22.1,Pulmonary embolism,1,17180181
0,22.1,Livedo reticularis,6,17180210
1,22.1,Necrosis,6,17180210
2,22.1,Livedo reticularis,1,17180210
3,22.1,Haemorrhage,6,17180210
0,22.1,Heart rate decreased,6,17180219
1,22.1,Dyspnoea,6,17180219
0,22.1,Starvation,6,17180220
1,22.1,Decreased appetite,6,17180220
2,22.1,Nausea,6,17180220
3,22.1,Epigastric discomfort,6,17180220
4,22.1,Drug intolerance,6,17180220
0,22.1,Decreased appetite,6,17180222
1,22.1,Nausea,6,17180222
2,22.1,Malaise,6,17180222
3,22.1,Dyspnoea,6,17180222
4,22.1,Anaemia,1,17180222
5,22.1,Haematemesis,6,17180222
6,22.1,Altered state of consciousness,6,17180222
7,22.1,Diarrhoea,6,17180222
8,22.1,Haemorrhage,6,17180222
0,22.1,Pneumonia,6,17180246
1,22.1,Chronic obstructive pulmonary disease,6,17180246
0,22.1,Stomatitis,1,17180368
1,22.1,Febrile neutropenia,1,17180368
0,22.1,Device expulsion,1,17180396
0,22.1,Abdominal lymphadenopathy,3,17180440
1,22.1,Clubbing,3,17180440
2,22.1,Progesterone receptor assay positive,3,17180440
3,22.1,Hepatic steatosis,3,17180440
4,22.1,Metastases to liver,3,17180440
5,22.1,Pelvic mass,3,17180440
6,22.1,Arthralgia,3,17180440
7,22.1,Frequent bowel movements,3,17180440
8,22.1,Oestrogen receptor assay positive,3,17180440
9,22.1,Palmar-plantar erythrodysaesthesia syndrome,3,17180440
10,22.1,Urge incontinence,3,17180440
11,22.1,Carbohydrate antigen 15-3 increased,3,17180440
12,22.1,Dysuria,3,17180440
13,22.1,Human epidermal growth factor receptor negative,3,17180440
14,22.1,Back pain,3,17180440
15,22.1,Uterine leiomyoma,3,17180440
16,22.1,Breast cancer metastatic,3,17180440
17,22.1,Ovarian mass,3,17180440
18,22.1,Uterine enlargement,3,17180440
19,22.1,Vertebral column mass,3,17180440
0,22.1,Acute respiratory failure,4,17180457
1,22.1,Pulmonary embolism,4,17180457
2,22.1,Acute kidney injury,1,17180457
3,22.1,Pneumonitis,4,17180457
0,22.1,Metastases to central nervous system,6,17180484
1,22.1,Metastases to spine,6,17180484
2,22.1,Malignant neoplasm progression,6,17180484
3,22.1,Brain oedema,6,17180484
4,22.1,Altered state of consciousness,6,17180484
5,22.1,Product use in unapproved indication,6,17180484
0,22.1,Febrile neutropenia,1,17180489
1,22.1,Neoplasm progression,6,17180489
2,22.1,Granulocytopenia,6,17180489
0,22.1,Oedema mouth,6,17180526
0,22.1,Pelvic pain,,17180529
1,22.1,Ilium fracture,6,17180529
2,22.1,Decreased appetite,,17180529
3,22.1,Platelet count decreased,3,17180529
4,22.1,Hormone-refractory prostate cancer,5,17180529
0,22.1,Enterocolitis,6,17180533
0,22.1,Erythema,1,17180544
1,22.1,Anxiety,1,17180544
2,22.1,Dyspnoea,1,17180544
3,22.1,Bronchospasm,1,17180544
0,22.1,Adverse event,2,17180561
0,22.1,Paronychia,3,17180569
1,22.1,Neutropenia,1,17180569
2,22.1,Acne,3,17180569
3,22.1,Pneumonia,1,17180569
0,22.1,Dry mouth,6,17180581
1,22.1,Diarrhoea,6,17180581
2,22.1,Anxiety,2,17180581
3,22.1,Localised infection,3,17180581
4,22.1,Decreased appetite,1,17180581
5,22.1,Mucosal inflammation,6,17180581
6,22.1,Dry skin,3,17180581
7,22.1,Ocular vascular disorder,3,17180581
8,22.1,Dyspnoea,3,17180581
9,22.1,Fatigue,3,17180581
10,22.1,Constipation,6,17180581
11,22.1,Rash,2,17180581
12,22.1,Dysphagia,6,17180581
13,22.1,General physical health deterioration,1,17180581
0,22.1,Gastrointestinal toxicity,1,17180584
0,22.1,Decreased immune responsiveness,1,17180588
0,22.1,Neutropenia,6,17180725
1,22.1,Thrombocytopenia,6,17180725
2,22.1,Nausea,6,17180725
3,22.1,Vomiting,6,17180725
4,22.1,Malaise,6,17180725
5,22.1,Proteinuria,6,17180725
6,22.1,Hypertension,6,17180725
7,22.1,Diarrhoea,6,17180725
8,22.1,Anaemia,6,17180725
0,22.1,Respiratory tract infection viral,3,17180740
1,22.1,Respiratory tract infection,1,17180740
0,22.1,Prescribed underdose,6,17180753
1,22.1,Interstitial lung disease,2,17180753
0,22.1,Malignant neoplasm progression,6,17180754
1,22.1,Back pain,1,17180754
0,22.1,Delirium,2,17180764
0,22.1,Intercepted product preparation error,,17180782
1,22.1,Product physical consistency issue,,17180782
0,22.1,Intercepted product preparation error,,17180795
1,22.1,Syringe issue,,17180795
2,22.1,Device leakage,,17180795
3,22.1,Wrong technique in product usage process,,17180795
0,22.1,Erythema nodosum,6,17180831
1,22.1,Enterocolitis,6,17180831
2,22.1,Rib fracture,6,17180831
3,22.1,Hypersensitivity,6,17180831
4,22.1,Cardiotoxicity,6,17180831
0,22.1,Conjunctivitis,3,17180832
0,22.1,Pyrexia,1,17180834
0,22.1,Nerve compression,,17180871
1,22.1,Prostate cancer metastatic,,17180871
2,22.1,Staphylococcal infection,,17180871
3,22.1,Hypoaesthesia,2,17180871
4,22.1,Pleural effusion,,17180871
0,22.1,Product use in unapproved indication,6,17180894
1,22.1,Retinal detachment,3,17180894
0,22.1,Cerebrovascular accident,6,17180903
1,22.1,Headache,2,17180903
2,22.1,Blood pressure increased,3,17180903
3,22.1,Lymphadenopathy,6,17180903
4,22.1,Musculoskeletal stiffness,6,17180903
5,22.1,Lung disorder,6,17180903
6,22.1,Abdominal discomfort,6,17180903
7,22.1,Dyspepsia,6,17180903
8,22.1,Dry eye,2,17180903
9,22.1,Diarrhoea,1,17180903
10,22.1,Fatigue,3,17180903
11,22.1,Nausea,3,17180903
12,22.1,Peripheral coldness,6,17180903
13,22.1,Cough,3,17180903
14,22.1,Weight decreased,3,17180903
15,22.1,Glossodynia,3,17180903
16,22.1,Visual impairment,3,17180903
17,22.1,Pulmonary congestion,6,17180903
18,22.1,Decreased appetite,6,17180903
19,22.1,Tooth disorder,3,17180903
20,22.1,Constipation,1,17180903
21,22.1,Secretion discharge,3,17180903
22,22.1,Vomiting,3,17180903
23,22.1,Dyspnoea,2,17180903
24,22.1,Mental impairment,6,17180903
25,22.1,Influenza like illness,3,17180903
26,22.1,Pneumonia,1,17180903
27,22.1,Dysphagia,3,17180903
0,22.1,Bone marrow failure,1,17180908
0,22.1,Acute kidney injury,2,17180910
1,22.1,Atrial fibrillation,1,17180910
2,22.1,Colitis,2,17180910
3,22.1,Diarrhoea,1,17180910
4,22.1,Hypokalaemia,1,17180910
0,22.1,Arteritis,4,17180952
0,22.1,Neutropenia,2,17181081
0,22.1,Pruritus,1,17181085
1,22.1,Rash,1,17181085
2,22.1,Hypotension,1,17181085
3,22.1,Visual impairment,1,17181085
4,22.1,Oxygen saturation decreased,1,17181085
0,22.1,Vena cava thrombosis,1,17181149
0,22.1,Pneumonia,6,17181174
1,22.1,Renal failure,6,17181174
2,22.1,Drug-induced liver injury,5,17181174
3,22.1,Portal vein thrombosis,6,17181174
4,22.1,Atrial fibrillation,6,17181174
5,22.1,Pneumonitis,6,17181174
0,22.1,Eye injury,1,17181293
1,22.1,Rash,6,17181293
0,22.1,Nausea,1,17181327
1,22.1,Asthenia,1,17181327
2,22.1,Vomiting,1,17181327
3,22.1,Neutropenia,1,17181327
0,22.1,Skin exfoliation,3,17181336
1,22.1,Stomatitis,3,17181336
2,22.1,Dyspnoea,3,17181336
3,22.1,Erythema,3,17181336
4,22.1,Stevens-Johnson syndrome,3,17181336
5,22.1,Blister,3,17181336
6,22.1,Pyrexia,3,17181336
7,22.1,Rash,3,17181336
0,22.1,Failure to thrive,1,17181408
1,22.1,Vomiting,1,17181408
2,22.1,Mean cell haemoglobin decreased,6,17181408
3,22.1,Palpitations,6,17181408
4,22.1,Brain natriuretic peptide increased,6,17181408
5,22.1,Atrial fibrillation,1,17181408
6,22.1,Anal incontinence,6,17181408
7,22.1,Decreased appetite,6,17181408
8,22.1,Aortic arteriosclerosis,6,17181408
9,22.1,Alanine aminotransferase decreased,6,17181408
10,22.1,Asthenia,6,17181408
11,22.1,Abdominal pain,6,17181408
12,22.1,Arteriosclerosis coronary artery,6,17181408
13,22.1,Blood glucose increased,6,17181408
14,22.1,Haemoglobin decreased,6,17181408
15,22.1,Heart rate increased,6,17181408
16,22.1,Urinary incontinence,6,17181408
17,22.1,Blood alkaline phosphatase decreased,6,17181408
18,22.1,Haematocrit decreased,6,17181408
19,22.1,Blood pressure decreased,6,17181408
20,22.1,Adrenal mass,6,17181408
21,22.1,Red cell distribution width increased,6,17181408
22,22.1,Monocyte count decreased,6,17181408
23,22.1,Dehydration,6,17181408
24,22.1,Diarrhoea,6,17181408
25,22.1,Nausea,1,17181408
26,22.1,Atelectasis,6,17181408
27,22.1,Lipase decreased,6,17181408
28,22.1,Red blood cell count decreased,6,17181408
0,22.1,Tumour marker increased,6,17181419
1,22.1,Metastases to bone,6,17181419
2,22.1,Malignant neoplasm progression,6,17181419
0,22.1,Hyperhidrosis,1,17181437
1,22.1,Pain,1,17181437
2,22.1,Chest discomfort,1,17181437
3,22.1,Dyspnoea,1,17181437
0,22.1,Off label use,6,17181443
1,22.1,Death,5,17181443
0,22.1,Feeling abnormal,6,17181465
1,22.1,Decreased appetite,6,17181465
0,22.1,Weight decreased,6,17181527
1,22.1,Death,5,17181527
2,22.1,Headache,6,17181527
0,22.1,Immune-mediated hepatitis,2,17181661
1,22.1,Pathological fracture,6,17181661
0,22.1,Immune system disorder,2,17181685
0,22.1,Dry skin,3,17181688
1,22.1,Pruritus,6,17181688
2,22.1,Rash,3,17181688
3,22.1,Erythema,6,17181688
0,22.1,Metastases to bone,6,17181690
1,22.1,Metastases to liver,6,17181690
2,22.1,Malignant neoplasm progression,6,17181690
3,22.1,Breast cancer,6,17181690
0,22.1,White blood cell count decreased,6,17181703
1,22.1,Pyrexia,6,17181703
2,22.1,Nephrostomy,6,17181703
3,22.1,Diarrhoea,6,17181703
4,22.1,Nasopharyngitis,6,17181703
0,22.1,Off label use,6,17181727
1,22.1,Hepatic cancer,6,17181727
0,22.1,Device expulsion,3,17181784
0,22.1,Nausea,1,17181793
1,22.1,Vomiting,1,17181793
0,22.1,Gastrooesophageal reflux disease,1,17181912
1,22.1,Fatigue,1,17181912
2,22.1,Dysphagia,1,17181912
3,22.1,Dyspnoea,1,17181912
4,22.1,Dysphonia,1,17181912
0,22.1,Intentional product use issue,6,17181950
1,22.1,Death,5,17181950
0,22.1,Device expulsion,1,17181988
0,22.1,Intentional product use issue,6,17182018
1,22.1,Malignant neoplasm progression,6,17182018
2,22.1,Squamous cell carcinoma,6,17182018
3,22.1,Lichenoid keratosis,6,17182018
0,22.1,Haemorrhage,6,17182072
1,22.1,Contusion,3,17182072
2,22.1,Constipation,1,17182072
3,22.1,Nausea,1,17182072
4,22.1,Platelet count decreased,3,17182072
5,22.1,Weight decreased,6,17182072
6,22.1,Underdose,6,17182072
7,22.1,Depression,1,17182072
8,22.1,Neuropathy peripheral,2,17182072
9,22.1,Rotator cuff syndrome,6,17182072
10,22.1,Fatigue,3,17182072
0,22.1,Hypertensive urgency,1,17182074
0,22.1,Metastases to central nervous system,6,17182096
0,22.1,Malignant neoplasm progression,6,17182123
1,22.1,Carbohydrate antigen 125 increased,6,17182123
0,22.1,Cholelithiasis,1,17182140
0,22.1,Metastases to central nervous system,3,17182143
1,22.1,Seizure,1,17182143
0,22.1,Hepatic enzyme abnormal,3,17182146
1,22.1,Pyrexia,1,17182146
2,22.1,Hypocalcaemia,3,17182146
3,22.1,Haemoglobin decreased,3,17182146
4,22.1,Neutropenia,3,17182146
0,22.1,Gastroenteritis,1,17182148
0,22.1,Erythema,6,17182173
1,22.1,Urticaria,6,17182173
2,22.1,Therapeutic response decreased,3,17182173
3,22.1,Mouth swelling,6,17182173
4,22.1,Stomatitis,3,17182173
5,22.1,Anaphylactic reaction,6,17182173
6,22.1,Pruritus,6,17182173
7,22.1,Flushing,6,17182173
8,22.1,Rash,6,17182173
0,22.1,Erythema,6,17182177
1,22.1,Feeling hot,6,17182177
0,22.1,General physical health deterioration,6,17182205
0,22.1,Adverse event,6,17182222
1,22.1,Device related infection,6,17182222
0,22.1,Haemorrhage,6,17182256
0,22.1,VIIIth nerve injury,6,17182263
0,22.1,General physical health deterioration,2,17182285
1,22.1,Fatigue,3,17182285
2,22.1,Depression,3,17182285
3,22.1,Dry mouth,3,17182285
4,22.1,Pain,6,17182285
5,22.1,Decreased appetite,2,17182285
6,22.1,Fatigue,6,17182285
7,22.1,Pain,2,17182285
8,22.1,Dyspnoea,2,17182285
9,22.1,Anxiety,3,17182285
0,22.1,Pneumothorax,6,17182293
0,22.1,Encephalopathy,1,17182305
0,22.1,Death,5,17182334
0,22.1,Death,5,17182486
1,22.1,Alopecia,6,17182486
2,22.1,Peripheral swelling,6,17182486
3,22.1,Off label use,6,17182486
4,22.1,Contusion,6,17182486
0,22.1,Transfusion,6,17182533
1,22.1,Death,5,17182533
0,22.1,Chemotherapy,6,17182570
0,22.1,Ovarian cancer,6,17182630
1,22.1,Proteinuria,1,17182630
0,22.1,Skin irritation,2,17182682
1,22.1,Off label use,6,17182682
2,22.1,Rash,2,17182682
0,22.1,Insomnia,3,17182792
1,22.1,Stridor,3,17182792
2,22.1,Diarrhoea,3,17182792
3,22.1,Malignant neoplasm progression,3,17182792
4,22.1,Hyperventilation,1,17182792
5,22.1,Hypokalaemia,3,17182792
6,22.1,Nausea,1,17182792
7,22.1,Renal failure,3,17182792
0,22.1,Haemorrhagic tumour necrosis,6,17182918
1,22.1,Febrile neutropenia,3,17182918
2,22.1,Multiple organ dysfunction syndrome,5,17182918
0,22.1,Hepatitis,3,17183033
1,22.1,Liver function test increased,3,17183033
0,22.1,Large intestine perforation,4,17183057
1,22.1,General physical health deterioration,1,17183057
0,22.1,Aspartate aminotransferase increased,3,17183081
1,22.1,Pulmonary embolism,3,17183081
2,22.1,Oedema peripheral,3,17183081
3,22.1,Anxiety,3,17183081
4,22.1,Fatigue,3,17183081
5,22.1,Mucosal inflammation,3,17183081
6,22.1,Alopecia,3,17183081
7,22.1,Breast cancer,3,17183081
8,22.1,Headache,3,17183081
9,22.1,Nasopharyngitis,3,17183081
10,22.1,Vomiting,3,17183081
11,22.1,Nausea,3,17183081
12,22.1,Malignant neoplasm progression,3,17183081
13,22.1,Oral pain,3,17183081
14,22.1,Alanine aminotransferase increased,3,17183081
15,22.1,Insomnia,3,17183081
16,22.1,Pyrexia,3,17183081
0,22.1,Death,5,17183084
1,22.1,Hospitalisation,6,17183084
0,22.1,Febrile neutropenia,1,17183223
1,22.1,Diarrhoea,1,17183223
2,22.1,Anaemia,1,17183223
0,22.1,Pneumonia,2,17183258
1,22.1,Malignant neoplasm progression,2,17183258
2,22.1,Hypertension,6,17183258
3,22.1,Diabetes mellitus,2,17183258
4,22.1,Weight decreased,2,17183258
5,22.1,Drug intolerance,2,17183258
6,22.1,Asthenia,2,17183258
7,22.1,Gait inability,2,17183258
8,22.1,Renal cancer,2,17183258
9,22.1,Depressed mood,2,17183258
0,22.1,Metastases to liver,6,17183273
1,22.1,Neutropenia,6,17183273
2,22.1,Polyneuropathy,6,17183273
3,22.1,Leukopenia,6,17183273
4,22.1,Lymphadenopathy,6,17183273
5,22.1,Rash pustular,6,17183273
0,22.1,Liver disorder,2,17183297
0,22.1,Death,5,17183302
1,22.1,Acquired gene mutation,6,17183302
0,22.1,Pulmonary thrombosis,6,17183365
0,22.1,Paraesthesia,6,17183379
1,22.1,Tremor,6,17183379
0,22.1,Malignant neoplasm progression,6,17183411
1,22.1,Death,5,17183411
2,22.1,Gene mutation,6,17183411
3,22.1,Breast cancer,6,17183411
0,22.1,Pyelonephritis,2,17183450
1,22.1,Neutropenia,1,17183450
0,22.1,Condition aggravated,3,17183461
1,22.1,Death,5,17183461
0,22.1,Sudden death,5,17183470
0,22.1,Neuropathy peripheral,6,17183473
1,22.1,Hereditary motor and sensory neuropathy,6,17183473
0,22.1,Hot flush,6,17183504
1,22.1,Fluid overload,1,17183504
2,22.1,Oedema peripheral,1,17183504
3,22.1,Depression,6,17183504
4,22.1,Weight decreased,1,17183504
0,22.1,Blood glucose increased,6,17183516
0,22.1,Death,5,17183532
0,22.1,Osteonecrosis of jaw,1,17183542
1,22.1,Product use in unapproved indication,6,17183542
0,22.1,Headache,6,17183561
1,22.1,Somnolence,6,17183561
2,22.1,Muscle spasms,6,17183561
3,22.1,Fatigue,6,17183561
0,22.1,Bone marrow failure,1,17183575
0,22.1,Bone marrow failure,1,17183579
0,22.1,Dysuria,6,17183591
1,22.1,Pollakiuria,6,17183591
2,22.1,Haemorrhage urinary tract,6,17183591
3,22.1,Constipation,6,17183591
4,22.1,Haematochezia,6,17183591
5,22.1,Blood urine present,6,17183591
6,22.1,Pollakiuria,1,17183591
0,22.1,Product size issue,6,17183599
1,22.1,Product use complaint,3,17183599
2,22.1,Dysphagia,3,17183599
3,22.1,Oesophageal carcinoma,3,17183599
0,22.1,Death,5,17183659
0,22.1,Death,5,17183661
0,22.1,Diarrhoea,6,17183673
1,22.1,Fatigue,6,17183673
2,22.1,Depression,3,17183673
3,22.1,Anxiety,6,17183673
4,22.1,Wrong dose,6,17183673
5,22.1,Decreased appetite,6,17183673
6,22.1,Poor quality sleep,1,17183673
7,22.1,Palpitations,1,17183673
8,22.1,Neuropathy peripheral,3,17183673
9,22.1,Alopecia,6,17183673
10,22.1,Nausea,6,17183673
11,22.1,Limb injury,6,17183673
0,22.1,Tonic convulsion,1,17183694
1,22.1,Rhonchi,1,17183694
2,22.1,Blood pressure immeasurable,1,17183694
3,22.1,Oxygen saturation decreased,1,17183694
4,22.1,Loss of consciousness,1,17183694
0,22.1,Panic attack,3,17183707
1,22.1,Somnolence,3,17183707
2,22.1,Asthenia,3,17183707
3,22.1,Abdominal distension,3,17183707
4,22.1,Headache,3,17183707
5,22.1,Dyskinesia,3,17183707
6,22.1,Nausea,3,17183707
7,22.1,Feeling jittery,3,17183707
8,22.1,Headache,1,17183707
9,22.1,Nervousness,3,17183707
10,22.1,Blindness transient,3,17183707
0,22.1,Heart rate increased,3,17183717
1,22.1,Thyroid disorder,3,17183717
2,22.1,Peripheral swelling,3,17183717
3,22.1,Oxygen saturation decreased,3,17183717
0,22.1,Nausea,6,17183744
1,22.1,Vomiting,6,17183744
2,22.1,Death,5,17183744
0,22.1,Malignant neoplasm progression,6,17183768
1,22.1,Haematotoxicity,6,17183768
0,22.1,Platelet count decreased,6,17183773
1,22.1,Thrombosis,6,17183773
0,22.1,Metastases to lung,5,17183820
1,22.1,General physical health deterioration,5,17183820
2,22.1,Pain in extremity,6,17183820
3,22.1,Injection site pain,1,17183820
4,22.1,Sleep disorder,3,17183820
5,22.1,Pruritus,3,17183820
6,22.1,Lymphoedema,3,17183820
7,22.1,Fatigue,3,17183820
8,22.1,Hot flush,3,17183820
9,22.1,Nausea,3,17183820
10,22.1,Metastases to central nervous system,5,17183820
11,22.1,Axillary pain,6,17183820
12,22.1,Peripheral swelling,3,17183820
0,22.1,Renal failure,2,17183821
1,22.1,Pain,2,17183821
2,22.1,Nausea,2,17183821
3,22.1,Vomiting,2,17183821
0,22.1,Interstitial lung disease,5,17183826
0,22.1,Fatigue,3,17183840
1,22.1,Pleural effusion,3,17183840
0,22.1,Burning sensation,,17183842
1,22.1,Nausea,,17183842
2,22.1,Infusion related reaction,,17183842
0,22.1,Oesophageal stenosis,1,17183855
0,22.1,Cataract,1,17183859
0,22.1,Anaphylactic reaction,6,17183866
0,22.1,Placental disorder,1,17183867
1,22.1,Foetal growth restriction,1,17183867
2,22.1,Maternal exposure during pregnancy,1,17183867
0,22.1,Abdominal pain,1,17183878
0,22.1,Death,5,17184027
1,22.1,Hypersomnia,,17184027
0,22.1,Hospitalisation,,17184230
0,22.1,Acute generalised exanthematous pustulosis,1,17184278
0,22.1,Neutropenia,2,17184290
1,22.1,Hypokalaemia,1,17184290
2,22.1,Hyponatraemia,2,17184290
3,22.1,Phlebitis,2,17184290
4,22.1,Nausea,2,17184290
5,22.1,Anaemia,2,17184290
0,22.1,Troponin increased,2,17184333
1,22.1,Infusion site pain,2,17184333
2,22.1,Chest pain,2,17184333
3,22.1,Cough,2,17184333
0,22.1,Skin odour abnormal,1,17184402
1,22.1,Fatigue,3,17184402
2,22.1,Feeling abnormal,3,17184402
3,22.1,Epistaxis,3,17184402
0,22.1,Product dose omission,6,17184407
1,22.1,Arthralgia,2,17184407
2,22.1,Chest pain,1,17184407
3,22.1,Pain,2,17184407
4,22.1,Malaise,6,17184407
0,22.1,Hypertension,6,17184416
0,22.1,Blood count abnormal,1,17184423
0,22.1,Nausea,6,17184438
1,22.1,Fatigue,6,17184438
0,22.1,Arthralgia,3,17184441
0,22.1,Skin lesion,6,17184444
0,22.1,Alopecia,3,17184445
0,22.1,Pain,,17184461
1,22.1,Fall,,17184461
0,22.1,Fatigue,3,17184479
1,22.1,Sinus congestion,3,17184479
2,22.1,Sinusitis,1,17184479
3,22.1,Diarrhoea,6,17184479
4,22.1,Hot flush,6,17184479
5,22.1,Full blood count decreased,6,17184479
0,22.1,Fatigue,6,17184514
1,22.1,Depression,6,17184514
2,22.1,White blood cell count decreased,6,17184514
3,22.1,Mental fatigue,6,17184514
0,22.1,Diarrhoea,3,17184515
1,22.1,Fatigue,3,17184515
0,22.1,Dry throat,6,17184520
1,22.1,Dyspnoea,6,17184520
2,22.1,Decreased appetite,6,17184520
3,22.1,Oropharyngeal pain,6,17184520
0,22.1,Bone pain,6,17184559
1,22.1,Arthralgia,6,17184559
2,22.1,Fatigue,6,17184559
3,22.1,Back pain,6,17184559
4,22.1,Acute kidney injury,6,17184559
5,22.1,Prescribed underdose,6,17184559
6,22.1,Pain in extremity,6,17184559
0,22.1,Alopecia,3,17184567
0,22.1,Neoplasm progression,6,17184572
0,22.1,Alopecia,3,17184573
1,22.1,Madarosis,3,17184573
2,22.1,Hair colour changes,3,17184573
3,22.1,Hair texture abnormal,3,17184573
4,22.1,Hair disorder,3,17184573
0,22.1,Orthostatic hypotension,1,17184589
0,22.1,Malignant neoplasm progression,6,17184610
1,22.1,Breast cancer metastatic,6,17184610
0,22.1,Chest pain,1,17184621
1,22.1,Pyrexia,1,17184621
2,22.1,Pneumonitis,1,17184621
3,22.1,Abdominal pain upper,1,17184621
4,22.1,Neutropenia,1,17184621
0,22.1,Gastroenteritis,1,17184657
0,22.1,Off label use,,17184674
1,22.1,Hepatic cancer,2,17184674
0,22.1,Haemoglobin decreased,1,17184753
1,22.1,Hypoaesthesia,2,17184753
2,22.1,Platelet count decreased,1,17184753
0,22.1,Colitis,2,17184783
1,22.1,Cystitis haemorrhagic,2,17184783
0,22.1,Disseminated intravascular coagulation,3,17184834
1,22.1,Fractured ischium,3,17184834
2,22.1,Pubis fracture,3,17184834
3,22.1,Spinal cord oedema,2,17184834
4,22.1,Interstitial lung disease,5,17184834
0,22.1,Brain oedema,,17184854
1,22.1,Therapy cessation,,17184854
0,22.1,Acute myeloid leukaemia,5,17184933
1,22.1,Second primary malignancy,5,17184933
2,22.1,Cardiotoxicity,5,17184933
3,22.1,Cardiac arrest,5,17184933
0,22.1,Product use in unapproved indication,6,17184958
1,22.1,Hyperthyroidism,1,17184958
2,22.1,Dysphonia,1,17184958
3,22.1,Diplopia,1,17184958
4,22.1,Off label use,6,17184958
0,22.1,Disease progression,,17184989
0,22.1,Neutropenia,1,17184990
1,22.1,Blood count abnormal,1,17184990
2,22.1,Monocyte count decreased,6,17184990
3,22.1,White blood cell count decreased,6,17184990
4,22.1,Blister,3,17184990
5,22.1,Decreased appetite,3,17184990
6,22.1,Basophil count increased,6,17184990
7,22.1,Tumour marker increased,3,17184990
8,22.1,Vomiting,1,17184990
9,22.1,Fatigue,3,17184990
10,22.1,Weight decreased,3,17184990
11,22.1,Dry skin,3,17184990
0,22.1,Death,5,17185069
0,22.1,Product dose omission,6,17185086
1,22.1,Death,5,17185086
0,22.1,Erythema,2,17185093
1,22.1,Burning sensation,2,17185093
0,22.1,Death,5,17185150
1,22.1,Off label use,6,17185150
0,22.1,Vena cava thrombosis,1,17185152
0,22.1,Colitis,,17185208
0,22.1,Blister,6,17185435
1,22.1,Dermatitis contact,6,17185435
0,22.1,Weight increased,6,17185437
1,22.1,Swelling face,6,17185437
2,22.1,Headache,6,17185437
3,22.1,Flushing,6,17185437
0,22.1,Rash maculo-papular,2,17185438
1,22.1,Hepatocellular injury,3,17185438
0,22.1,Hypersomnia,6,17185459
1,22.1,Monoparesis,6,17185459
2,22.1,Insomnia,6,17185459
3,22.1,Drug ineffective,6,17185459
4,22.1,Neuralgia,6,17185459
5,22.1,Chest pain,6,17185459
0,22.1,Malaise,3,17185521
1,22.1,Drug ineffective,3,17185521
2,22.1,Drug screen negative,3,17185521
0,22.1,Malignant neoplasm progression,6,17185563
1,22.1,Metastases to bone,6,17185563
2,22.1,Breast cancer,6,17185563
0,22.1,Malignant neoplasm progression,6,17185589
1,22.1,Breast cancer,6,17185589
0,22.1,Osteonecrosis of jaw,3,17185591
0,22.1,Deafness neurosensory,6,17185630
0,22.1,Hospitalisation,6,17185680
1,22.1,Disease progression,5,17185680
2,22.1,Diarrhoea,6,17185680
3,22.1,Fatigue,6,17185680
0,22.1,Dizziness,1,17185681
1,22.1,Fatigue,3,17185681
2,22.1,Cardiac disorder,6,17185681
3,22.1,Nausea,3,17185681
4,22.1,Decreased appetite,3,17185681
5,22.1,Night sweats,6,17185681
6,22.1,Diarrhoea,3,17185681
7,22.1,Constipation,6,17185681
8,22.1,Adverse drug reaction,6,17185681
9,22.1,Off label use,6,17185681
0,22.1,Dyspnoea,6,17185687
1,22.1,Abdominal distension,5,17185687
2,22.1,Decreased appetite,6,17185687
3,22.1,Listless,6,17185687
4,22.1,Ascites,5,17185687
0,22.1,Interstitial lung disease,5,17185700
0,22.1,Death,5,17185725
0,22.1,Death,5,17185734
0,22.1,Bradycardia,5,17185798
1,22.1,Dehydration,5,17185798
2,22.1,Hypotension,5,17185798
3,22.1,Cardio-respiratory arrest,5,17185798
4,22.1,Abdominal pain,5,17185798
5,22.1,Diarrhoea,5,17185798
0,22.1,Diverticulitis,2,17185905
0,22.1,Pneumonia,5,17185911
1,22.1,Neutrophil count decreased,6,17185911
2,22.1,Cardiac failure congestive,5,17185911
3,22.1,Gastrointestinal perforation,6,17185911
0,22.1,Hospitalisation,5,17185927
1,22.1,Death,5,17185927
0,22.1,Alanine aminotransferase increased,1,17185943
1,22.1,Mucosal inflammation,1,17185943
2,22.1,Leukopenia,5,17185943
3,22.1,Stomatitis,1,17185943
4,22.1,Diarrhoea,1,17185943
5,22.1,Laboratory test abnormal,1,17185943
6,22.1,C-reactive protein increased,3,17185943
7,22.1,Non-small cell lung cancer,5,17185943
8,22.1,Blood alkaline phosphatase increased,3,17185943
0,22.1,Syncope,6,17185948
1,22.1,Alopecia,3,17185948
2,22.1,Lower respiratory tract infection,1,17185948
3,22.1,Fall,6,17185948
4,22.1,Leukopenia,1,17185948
5,22.1,Bone marrow failure,1,17185948
6,22.1,Condition aggravated,3,17185948
0,22.1,Red blood cell count decreased,6,17185954
1,22.1,Hypotension,6,17185954
2,22.1,Blood calcium decreased,6,17185954
3,22.1,Platelet count decreased,6,17185954
4,22.1,Asthenia,6,17185954
5,22.1,White blood cell count decreased,6,17185954
0,22.1,Anaemia,2,17185965
1,22.1,Thrombocytopenia,1,17185965
2,22.1,Neutropenia,1,17185965
3,22.1,Platelet count decreased,1,17185965
4,22.1,Off label use,6,17185965
0,22.1,Death,5,17185967
0,22.1,Fall,6,17185974
1,22.1,Dizziness,6,17185974
0,22.1,Metastases to lymph nodes,6,17186005
1,22.1,Breast cancer metastatic,6,17186005
2,22.1,Malignant neoplasm progression,6,17186005
0,22.1,Renal impairment,,17186008
0,22.1,Blood thyroid stimulating hormone,1,17186012
1,22.1,Fatigue,1,17186012
2,22.1,Vertigo,1,17186012
3,22.1,Suicidal ideation,1,17186012
4,22.1,Muscle spasms,1,17186012
5,22.1,Menstrual disorder,1,17186012
0,22.1,Pyrexia,1,17186022
1,22.1,Abdominal pain lower,1,17186022
2,22.1,Productive cough,1,17186022
3,22.1,Cough,1,17186022
4,22.1,Dyspnoea,1,17186022
5,22.1,Tremor,6,17186022
6,22.1,Fall,6,17186022
7,22.1,Constipation,1,17186022
8,22.1,Malignant neoplasm progression,5,17186022
9,22.1,Confusional state,6,17186022
0,22.1,Cardio-respiratory arrest,5,17186025
0,22.1,Cerebral infarction,5,17186044
1,22.1,Off label use,6,17186044
2,22.1,Bladder cancer,5,17186044
0,22.1,Ileus,,17186052
0,22.1,Pain,,17186053
1,22.1,Cough,,17186053
0,22.1,Metastases to bone,6,17186070
1,22.1,Pneumonia,6,17186070
2,22.1,Metastases to lymph nodes,6,17186070
0,22.1,Death,5,17186075
0,22.1,Radiation pneumonitis,2,17186077
0,22.1,Blood magnesium decreased,6,17186096
1,22.1,Headache,6,17186096
0,22.1,Death,5,17186132
0,22.1,Magnetic resonance imaging brain abnormal,6,17186138
0,22.1,Death,5,17186161
0,22.1,Malignant neoplasm progression,6,17186167
1,22.1,Condition aggravated,6,17186167
2,22.1,Drug resistance,6,17186167
0,22.1,Cataract,6,17186200
0,22.1,Drug ineffective,6,17186207
1,22.1,General physical health deterioration,3,17186207
2,22.1,PCO2 increased,3,17186207
3,22.1,Cardiomyopathy,3,17186207
4,22.1,Myositis,3,17186207
5,22.1,Transaminases increased,6,17186207
0,22.1,Pneumonia,5,17186215
0,22.1,Cardiac arrest,5,17186248
0,22.1,Orthostatic hypotension,3,17186267
1,22.1,Diarrhoea,3,17186267
2,22.1,Platelet count decreased,3,17186267
3,22.1,Stomatitis,1,17186267
4,22.1,Intestinal obstruction,1,17186267
5,22.1,Obstruction gastric,1,17186267
6,22.1,Benign prostatic hyperplasia,3,17186267
7,22.1,Hypersensitivity,1,17186267
8,22.1,Small intestinal obstruction,1,17186267
9,22.1,Cholangitis acute,1,17186267
10,22.1,Neutropenia,1,17186267
11,22.1,Anaemia,3,17186267
12,22.1,Pyrexia,1,17186267
0,22.1,Oropharyngeal pain,3,17186268
1,22.1,Dyspnoea,3,17186268
2,22.1,Anal haemorrhage,3,17186268
3,22.1,Neutropenia,3,17186268
4,22.1,Dry mouth,3,17186268
5,22.1,Eructation,3,17186268
6,22.1,Flatulence,3,17186268
7,22.1,Dehydration,1,17186268
8,22.1,Device related thrombosis,2,17186268
9,22.1,Vomiting,3,17186268
10,22.1,Hypertension,3,17186268
11,22.1,Nausea,3,17186268
12,22.1,Decreased appetite,3,17186268
13,22.1,Diarrhoea,3,17186268
14,22.1,Neutropenia,1,17186268
15,22.1,Rectal tenesmus,3,17186268
16,22.1,Rash,3,17186268
0,22.1,Hypotension,6,17186300
1,22.1,Cystitis,6,17186300
0,22.1,Mucosal inflammation,3,17186313
1,22.1,Anaemia,3,17186313
2,22.1,Bronchitis,3,17186313
3,22.1,Neoplasm progression,5,17186313
0,22.1,Cerebrovascular accident,5,17186328
0,22.1,Pruritus,3,17186395
1,22.1,Feeling abnormal,3,17186395
0,22.1,Hot flush,6,17186399
0,22.1,Anxiety,6,17186406
1,22.1,Decreased appetite,6,17186406
2,22.1,Dizziness,6,17186406
3,22.1,Productive cough,1,17186406
4,22.1,Candida infection,6,17186406
5,22.1,Hypokalaemia,6,17186406
6,22.1,Ageusia,6,17186406
7,22.1,Syncope,6,17186406
8,22.1,Pneumonia,6,17186406
9,22.1,Asthenia,6,17186406
10,22.1,Dehydration,2,17186406
0,22.1,Infection,1,17186408
1,22.1,Death,5,17186408
2,22.1,Urinary tract infection,3,17186408
3,22.1,Ileus,1,17186408
4,22.1,Aspiration,6,17186408
0,22.1,Aspiration,2,17186413
1,22.1,Ascites,1,17186413
0,22.1,Hair texture abnormal,6,17186420
1,22.1,Hair colour changes,6,17186420
2,22.1,Hair disorder,6,17186420
3,22.1,Alopecia,3,17186420
4,22.1,Madarosis,3,17186420
0,22.1,Septic shock,2,17186424
1,22.1,Acute respiratory failure,2,17186424
0,22.1,Accidental exposure to product,,17186428
1,22.1,Product leakage,,17186428
2,22.1,Intercepted product administration error,,17186428
0,22.1,Malignant neoplasm progression,6,17186443
1,22.1,Anaemia,2,17186443
0,22.1,Cholelithiasis,1,17186447
0,22.1,Injection site swelling,3,17186479
1,22.1,Injection site erythema,3,17186479
2,22.1,Neutropenia,3,17186479
0,22.1,Larynx irritation,1,17186502
1,22.1,Pruritus,1,17186502
2,22.1,Infusion related reaction,1,17186502
0,22.1,Neutropenia,2,17186514
1,22.1,Alopecia,2,17186514
2,22.1,Dementia,3,17186514
0,22.1,Neoplasm malignant,5,17186545
0,22.1,Ileus,5,17186551
0,22.1,Hepatitis,3,17186557
0,22.1,Urinary tract infection,6,17186585
0,22.1,Asthenia,6,17186586
1,22.1,Fall,6,17186586
2,22.1,Dehydration,6,17186586
3,22.1,Diarrhoea,6,17186586
0,22.1,Taste disorder,3,17186587
1,22.1,Back pain,3,17186587
2,22.1,Fatigue,3,17186587
3,22.1,Pain in extremity,3,17186587
4,22.1,Herpes zoster,3,17186587
5,22.1,Decreased appetite,3,17186587
6,22.1,Weight decreased,3,17186587
7,22.1,Gingival pain,3,17186587
8,22.1,Metastases to bone,6,17186587
0,22.1,Death,5,17186593
0,22.1,Malignant neoplasm progression,6,17186594
1,22.1,Death,5,17186594
0,22.1,Adverse event,6,17186596
0,22.1,Rash,6,17186612
1,22.1,Colorectal cancer metastatic,5,17186612
0,22.1,Depression,6,17186613
1,22.1,Neutropenia,6,17186613
2,22.1,Decreased appetite,1,17186613
3,22.1,Paraesthesia,3,17186613
0,22.1,Cardiac failure,2,17186617
0,22.1,Colitis,6,17186655
1,22.1,Death,5,17186655
2,22.1,Large intestine perforation,6,17186655
0,22.1,Arthralgia,6,17186693
1,22.1,Balance disorder,6,17186693
2,22.1,Breast cancer,6,17186693
3,22.1,Malignant neoplasm progression,6,17186693
4,22.1,Metastases to bone,6,17186693
5,22.1,Atypical femur fracture,6,17186693
0,22.1,Laboratory test abnormal,,17186708
1,22.1,Haemoglobin decreased,6,17186708
0,22.1,Enterocutaneous fistula,6,17186709
1,22.1,Diverticular perforation,6,17186709
2,22.1,Abdominal wall abscess,6,17186709
0,22.1,Myocardial infarction,6,17186713
1,22.1,Electrocardiogram PR shortened,6,17186713
2,22.1,Electrocardiogram QT shortened,6,17186713
3,22.1,Electrocardiogram abnormal,6,17186713
0,22.1,Stomatitis,6,17186754
1,22.1,Diarrhoea,1,17186754
2,22.1,Interstitial lung disease,5,17186754
3,22.1,Lymphangiosis carcinomatosa,6,17186754
0,22.1,Urethritis,6,17186755
1,22.1,Renal disorder,5,17186755
2,22.1,Blood urine present,5,17186755
3,22.1,Off label use,6,17186755
4,22.1,Pleural effusion,2,17186755
5,22.1,Product use in unapproved indication,6,17186755
0,22.1,Arthralgia,2,17186768
0,22.1,Hypotension,1,17186770
1,22.1,Anaemia,1,17186770
0,22.1,Pneumonia,5,17186771
1,22.1,Influenza,1,17186771
0,22.1,Asthenia,3,17186773
1,22.1,Psychiatric decompensation,3,17186773
2,22.1,Insomnia,3,17186773
3,22.1,Anxiety,3,17186773
4,22.1,Depression,3,17186773
0,22.1,Median nerve injury,6,17186788
1,22.1,Cough,6,17186788
2,22.1,Carpal tunnel syndrome,6,17186788
3,22.1,Intervertebral disc disorder,6,17186788
4,22.1,Aspartate aminotransferase increased,6,17186788
5,22.1,Paraesthesia,1,17186788
6,22.1,Peripheral sensory neuropathy,6,17186788
7,22.1,Alanine aminotransferase increased,6,17186788
8,22.1,Hypoaesthesia,1,17186788
9,22.1,Insomnia,6,17186788
10,22.1,Sleep disorder,6,17186788
11,22.1,Small fibre neuropathy,6,17186788
12,22.1,Fatigue,6,17186788
13,22.1,Somnolence,6,17186788
14,22.1,Gamma-glutamyltransferase increased,6,17186788
15,22.1,Feeling abnormal,1,17186788
16,22.1,Middle insomnia,6,17186788
17,22.1,Discomfort,6,17186788
18,22.1,Erythema,6,17186788
0,22.1,Cellulitis,3,17186811
1,22.1,Electrocardiogram QT prolonged,1,17186811
2,22.1,Stomatitis,1,17186811
3,22.1,Malignant neoplasm progression,6,17186811
4,22.1,Paronychia,3,17186811
5,22.1,Platelet count decreased,1,17186811
6,22.1,Renal impairment,1,17186811
7,22.1,Hepatic function abnormal,2,17186811
8,22.1,Decreased appetite,1,17186811
9,22.1,Skin ulcer,2,17186811
10,22.1,Hyperkalaemia,1,17186811
0,22.1,Thrombocytopenia,1,17186822
1,22.1,Leukopenia,1,17186822
2,22.1,Vertigo,3,17186822
3,22.1,Platelet count decreased,1,17186822
4,22.1,Infection,1,17186822
0,22.1,Bone marrow failure,1,17186846
0,22.1,Unevaluable event,6,17186883
1,22.1,Depression,6,17186883
0,22.1,Metastases to heart,6,17186886
1,22.1,Breast cancer metastatic,6,17186886
2,22.1,Metastases to bone,6,17186886
3,22.1,Metastases to liver,6,17186886
4,22.1,Metastases to lymph nodes,6,17186886
5,22.1,Metastases to lung,6,17186886
6,22.1,Malignant neoplasm progression,6,17186886
0,22.1,Adrenal gland cancer,6,17186949
1,22.1,Tumour marker increased,6,17186949
2,22.1,Neuropathy peripheral,6,17186949
3,22.1,Thrombocytopenia,6,17186949
4,22.1,Metastases to peritoneum,6,17186949
5,22.1,Malignant neoplasm progression,6,17186949
0,22.1,Stoma obstruction,1,17186960
1,22.1,Cystitis haemorrhagic,3,17186960
2,22.1,Muscle spasms,1,17186960
3,22.1,Rash,2,17186960
4,22.1,Flushing,3,17186960
5,22.1,Eye irritation,3,17186960
6,22.1,Chest pain,1,17186960
7,22.1,Vomiting,1,17186960
8,22.1,Malaise,1,17186960
9,22.1,Weight decreased,1,17186960
10,22.1,Dizziness,1,17186960
11,22.1,Proctalgia,3,17186960
12,22.1,Increased appetite,3,17186960
13,22.1,Dry skin,3,17186960
14,22.1,Diarrhoea,1,17186960
15,22.1,Ocular hyperaemia,3,17186960
16,22.1,Urinary tract infection,1,17186960
17,22.1,Dandruff,3,17186960
0,22.1,Acute kidney injury,1,17186961
1,22.1,Eosinophilia,1,17186961
0,22.1,Autoimmune encephalopathy,2,17186964
0,22.1,Ammonia increased,6,17186976
1,22.1,Confusional state,4,17186976
2,22.1,Malignant neoplasm progression,6,17186976
3,22.1,Asthenia,6,17186976
4,22.1,Mental impairment,6,17186976
0,22.1,Cerebral infarction,5,17187038
1,22.1,Drug ineffective,6,17187038
2,22.1,Prostate cancer,6,17187038
3,22.1,Anaemia,6,17187038
0,22.1,Pleural effusion,5,17187040
0,22.1,Eastern Cooperative Oncology Group performance status worsened,6,17187074
1,22.1,Neuropathy peripheral,3,17187074
2,22.1,Disease progression,3,17187074
3,22.1,Hospice care,3,17187074
0,22.1,Cardiac arrest,6,17187091
1,22.1,Product administration error,6,17187091
2,22.1,Off label use,6,17187091
0,22.1,Embolism,3,17187187
1,22.1,Pneumonia,2,17187187
0,22.1,Rash,6,17187204
0,22.1,Candida infection,2,17187312
1,22.1,Gout,6,17187312
2,22.1,Muscular weakness,6,17187312
3,22.1,Loss of personal independence in daily activities,6,17187312
4,22.1,Back pain,6,17187312
5,22.1,Dyspnoea exertional,2,17187312
6,22.1,Fatigue,3,17187312
7,22.1,Abdominal pain,6,17187312
8,22.1,Malaise,3,17187312
9,22.1,Anaemia,6,17187312
10,22.1,Pleural effusion,6,17187312
11,22.1,Pruritus,1,17187312
12,22.1,Abdominal pain upper,6,17187312
13,22.1,Gastritis,6,17187312
14,22.1,Nausea,6,17187312
15,22.1,Weight decreased,6,17187312
16,22.1,Oedema peripheral,6,17187312
0,22.1,Neck pain,1,17187318
1,22.1,Back pain,1,17187318
0,22.1,Therapeutic product effect incomplete,6,17187324
1,22.1,Toxicity to various agents,6,17187324
0,22.1,Dementia Alzheimer^s type,4,17187331
1,22.1,Hypertension,1,17187331
0,22.1,Rosacea,6,17187395
0,22.1,Flank pain,3,17187418
1,22.1,Thyroid cancer,6,17187418
2,22.1,Product use in unapproved indication,6,17187418
3,22.1,Malignant neoplasm progression,6,17187418
0,22.1,Haematoma,6,17187550
1,22.1,Peripheral swelling,6,17187550
2,22.1,Weight decreased,6,17187550
3,22.1,Pain in extremity,6,17187550
0,22.1,Stomatitis,6,17187560
0,22.1,Swelling face,6,17187563
0,22.1,Febrile neutropenia,1,17187660
1,22.1,Anaemia,3,17187660
2,22.1,White blood cell count decreased,1,17187660
0,22.1,Fall,6,17187697
1,22.1,Femur fracture,6,17187697
0,22.1,Product use issue,1,17187729
1,22.1,Drug ineffective,6,17187729
2,22.1,Abdominal pain,2,17187729
3,22.1,Aerophagia,1,17187729
4,22.1,Faeces hard,1,17187729
5,22.1,Dyschezia,2,17187729
6,22.1,Constipation,1,17187729
7,22.1,Diarrhoea,3,17187729
8,22.1,Proctalgia,1,17187729
9,22.1,Pain,3,17187729
10,22.1,Bowel movement irregularity,1,17187729
0,22.1,Death,5,17187734
0,22.1,Diarrhoea,5,17187750
1,22.1,Bradycardia,5,17187750
2,22.1,Hypotension,5,17187750
3,22.1,Abdominal pain,5,17187750
4,22.1,Cardio-respiratory arrest,5,17187750
5,22.1,Dehydration,5,17187750
0,22.1,Haematotoxicity,5,17187769
1,22.1,Underdose,6,17187769
2,22.1,Gastric cancer stage IV,5,17187769
3,22.1,Liver disorder,5,17187769
0,22.1,Pneumonia,6,17187774
1,22.1,Diffuse alveolar damage,2,17187774
0,22.1,Disease progression,5,17187778
1,22.1,Colorectal cancer metastatic,5,17187778
0,22.1,Death,5,17187788
1,22.1,Thrombocytopenia,6,17187788
2,22.1,Metastases to heart,6,17187788
3,22.1,Therapy partial responder,6,17187788
0,22.1,Fatigue,6,17187791
1,22.1,Malignant neoplasm progression,6,17187791
0,22.1,Renal impairment,2,17187815
0,22.1,Weight decreased,6,17187853
0,22.1,Gastrointestinal disorder,2,17187902
0,22.1,Febrile neutropenia,5,17187907
0,22.1,Myalgia,6,17187908
1,22.1,Diarrhoea,6,17187908
2,22.1,Neoplasm progression,6,17187908
0,22.1,Platelet count decreased,1,17187910
1,22.1,Aortitis,1,17187910
0,22.1,Skin exfoliation,6,17187951
1,22.1,Rash,6,17187951
2,22.1,Ascites,6,17187951
0,22.1,Hypoacusis,3,17187963
0,22.1,Chest pain,2,17187982
1,22.1,Chest discomfort,2,17187982
2,22.1,Oxygen saturation decreased,2,17187982
3,22.1,Asthenia,6,17187982
4,22.1,Back pain,2,17187982
5,22.1,Dyspnoea,2,17187982
6,22.1,Cough,2,17187982
0,22.1,Femur fracture,3,17187985
0,22.1,Haemoglobin decreased,6,17187986
1,22.1,White blood cell count decreased,6,17187986
2,22.1,Tachycardia,6,17187986
3,22.1,Cardiac failure,6,17187986
4,22.1,Atrial flutter,1,17187986
5,22.1,Arrhythmia,2,17187986
0,22.1,Malignant neoplasm progression,5,17188008
1,22.1,Mucosal inflammation,1,17188008
2,22.1,Leukopenia,1,17188008
0,22.1,Second primary malignancy,2,17188035
1,22.1,Skin mass,6,17188035
2,22.1,Koebner phenomenon,2,17188035
3,22.1,Lymphadenopathy,6,17188035
4,22.1,Product use in unapproved indication,6,17188035
5,22.1,Kaposi^s sarcoma,2,17188035
0,22.1,Malignant neoplasm progression,6,17188037
0,22.1,Acute lymphocytic leukaemia,5,17188053
1,22.1,Second primary malignancy,5,17188053
0,22.1,Erythema,3,17188058
1,22.1,Joint swelling,3,17188058
2,22.1,Hypersensitivity,3,17188058
3,22.1,Angioedema,3,17188058
0,22.1,Non-small cell lung cancer,5,17188060
1,22.1,Thrombocytopenia,3,17188060
0,22.1,Diarrhoea,1,17188076
1,22.1,Bradyphrenia,1,17188076
2,22.1,Chest pain,1,17188076
3,22.1,Blister,1,17188076
4,22.1,Mutism,1,17188076
0,22.1,Product use in unapproved indication,6,17188081
1,22.1,Inappropriate schedule of product administration,6,17188081
0,22.1,Cardio-respiratory arrest,5,17188098
0,22.1,Pyelonephritis,2,17188102
1,22.1,Pain,1,17188102
2,22.1,Neutropenia,1,17188102
0,22.1,Diarrhoea,1,17188109
1,22.1,Fatigue,1,17188109
2,22.1,Epistaxis,1,17188109
3,22.1,Leukopenia,1,17188109
4,22.1,Pruritus,1,17188109
5,22.1,Neutropenia,1,17188109
6,22.1,Stomatitis,1,17188109
0,22.1,Malignant neoplasm progression,6,17188131
0,22.1,Flushing,6,17188137
1,22.1,Respiratory fatigue,6,17188137
2,22.1,Leukopenia,6,17188137
3,22.1,Asthenia,6,17188137
4,22.1,Anaemia,6,17188137
0,22.1,Off label use,6,17188146
0,22.1,Diarrhoea,2,17188159
1,22.1,Nausea,2,17188159
2,22.1,Pancytopenia,2,17188159
0,22.1,Death,5,17188253
0,22.1,Death,5,17188254
0,22.1,Malaise,1,17188260
1,22.1,Hyponatraemia,1,17188260
2,22.1,Pyrexia,1,17188260
0,22.1,Inflammation,6,17188265
1,22.1,Breast cancer,6,17188265
2,22.1,Metastasis,6,17188265
3,22.1,Weight decreased,6,17188265
4,22.1,Lymphadenitis,6,17188265
5,22.1,Peripheral swelling,6,17188265
6,22.1,Stomatitis,1,17188265
7,22.1,Spinal cord disorder,6,17188265
8,22.1,Decreased appetite,6,17188265
9,22.1,Malignant neoplasm progression,6,17188265
10,22.1,Drug ineffective,6,17188265
0,22.1,Medication error,3,17188298
1,22.1,Memory impairment,3,17188298
0,22.1,Product dose omission,6,17188326
0,22.1,Pancytopenia,1,17188406
1,22.1,Pyrexia,1,17188406
0,22.1,Nausea,1,17188407
1,22.1,Vomiting,1,17188407
2,22.1,Decreased appetite,6,17188407
3,22.1,Bone marrow failure,2,17188407
0,22.1,Nausea,6,17188442
1,22.1,Haemorrhage,6,17188442
2,22.1,Eating disorder,6,17188442
3,22.1,Mass,2,17188442
0,22.1,Tachypnoea,2,17188444
1,22.1,Stridor,2,17188444
0,22.1,Rash,6,17188462
0,22.1,Epistaxis,1,17188472
0,22.1,Hyperkalaemia,1,17188491
1,22.1,Vomiting,1,17188491
2,22.1,Malaise,1,17188491
3,22.1,Platelet count decreased,1,17188491
4,22.1,Constipation,1,17188491
5,22.1,Neutrophil count decreased,1,17188491
6,22.1,Anaemia,1,17188491
7,22.1,Decreased appetite,1,17188491
8,22.1,White blood cell count decreased,1,17188491
9,22.1,Nausea,1,17188491
10,22.1,Pyrexia,2,17188491
11,22.1,Alopecia,1,17188491
0,22.1,Drug ineffective,6,17188968
0,22.1,Therapy non-responder,6,17188982
1,22.1,Metastasis,6,17188982
2,22.1,Cardiac disorder,6,17188982
0,22.1,Interstitial lung disease,1,17188983
1,22.1,Metastases to central nervous system,6,17188983
2,22.1,Gastric ulcer haemorrhage,1,17188983
0,22.1,Therapy non-responder,5,17189000
1,22.1,Off label use,6,17189000
2,22.1,Hepatic failure,5,17189000
3,22.1,Product use in unapproved indication,5,17189000
4,22.1,Hepatic cancer metastatic,5,17189000
0,22.1,Lip dry,3,17189042
1,22.1,Rash,3,17189042
0,22.1,Febrile neutropenia,2,17189063
0,22.1,Cerebral infarction,6,17189103
1,22.1,Cardiomyopathy,2,17189103
0,22.1,Metastases to liver,6,17189159
1,22.1,Dyspnoea,5,17189159
2,22.1,Neuropathy peripheral,6,17189159
3,22.1,Blood pressure increased,6,17189159
4,22.1,Hepatotoxicity,6,17189159
5,22.1,Pulmonary embolism,6,17189159
6,22.1,Tachyarrhythmia,6,17189159
7,22.1,Pneumothorax,5,17189159
8,22.1,Breast cancer,5,17189159
9,22.1,Fatigue,6,17189159
10,22.1,Malignant neoplasm progression,5,17189159
0,22.1,Colorectal cancer metastatic,6,17189170
1,22.1,Disease progression,6,17189170
2,22.1,Rash,1,17189170
0,22.1,Asthenia,1,17189187
1,22.1,Neutropenia,1,17189187
2,22.1,Vomiting,1,17189187
3,22.1,Nausea,1,17189187
4,22.1,Drug interaction,6,17189187
0,22.1,Cardio-respiratory arrest,5,17189189
1,22.1,Bradycardia,5,17189189
2,22.1,Hypotension,5,17189189
3,22.1,Abdominal pain,5,17189189
4,22.1,Diarrhoea,5,17189189
5,22.1,Dehydration,5,17189189
0,22.1,Oral pain,6,17189191
1,22.1,Lichen planus,6,17189191
2,22.1,Neutropenia,6,17189191
0,22.1,Asthenia,2,17189194
1,22.1,Neutropenia,2,17189194
0,22.1,Blood thyroid stimulating hormone decreased,6,17189197
0,22.1,Bone marrow failure,2,17189216
0,22.1,Stevens-Johnson syndrome,6,17189232
0,22.1,Rash,2,17189241
0,22.1,Transaminases increased,6,17189254
0,22.1,Bone marrow failure,6,17189263
0,22.1,Neutropenia,6,17189275
1,22.1,Rash,6,17189275
2,22.1,Colitis,1,17189275
0,22.1,Interstitial lung disease,2,17189300
0,22.1,Fatigue,3,17189324
1,22.1,Nausea,1,17189324
2,22.1,Cholecystitis,1,17189324
3,22.1,Neutrophil count decreased,3,17189324
0,22.1,Swelling face,6,17189355
1,22.1,Skin disorder,3,17189355
0,22.1,Coma,6,17189379
1,22.1,Fall,6,17189379
2,22.1,Subdural haematoma,6,17189379
0,22.1,Neurotoxicity,6,17189393
1,22.1,Rash,6,17189393
0,22.1,Pulmonary embolism,5,17189413
1,22.1,Acute respiratory distress syndrome,5,17189413
2,22.1,Malaise,3,17189413
3,22.1,Multiple organ dysfunction syndrome,5,17189413
0,22.1,Adverse event,6,17189440
0,22.1,Acute hepatic failure,5,17189477
1,22.1,Autoimmune hepatitis,3,17189477
0,22.1,Hepatic function abnormal,3,17189495
1,22.1,Pyrexia,1,17189495
0,22.1,Pancytopenia,6,17189555
1,22.1,Death,5,17189555
0,22.1,Bone marrow failure,1,17189594
0,22.1,Death,5,17189608
0,22.1,Pneumonia,1,17189646
1,22.1,Hypoxia,1,17189646
0,22.1,Fatigue,3,17189652
1,22.1,Renal impairment,2,17189652
2,22.1,Product use issue,6,17189652
3,22.1,Blood potassium decreased,6,17189652
4,22.1,Nausea,3,17189652
5,22.1,Pyelocaliectasis,6,17189652
6,22.1,Dysgeusia,6,17189652
7,22.1,Vomiting,3,17189652
8,22.1,Blood pressure increased,3,17189652
0,22.1,Interstitial lung disease,2,17189694
0,22.1,Pyelonephritis acute,1,17189712
0,22.1,Off label use,6,17189752
1,22.1,Death,5,17189752
2,22.1,Intentional product use issue,6,17189752
0,22.1,Atrial fibrillation,1,17189760
1,22.1,Colitis ulcerative,3,17189760
2,22.1,Diarrhoea,4,17189760
0,22.1,Interstitial lung disease,3,17189839
1,22.1,Patella fracture,6,17189839
2,22.1,Fall,6,17189839
0,22.1,Neurotoxicity,6,17189852
1,22.1,Nephropathy toxic,6,17189852
2,22.1,Bone marrow failure,6,17189852
3,22.1,Anaphylactic reaction,6,17189852
4,22.1,Gastrointestinal disorder,6,17189852
5,22.1,Hepatotoxicity,6,17189852
6,22.1,Cardiotoxicity,6,17189852
0,22.1,Bone marrow failure,6,17189856
0,22.1,Nasopharyngitis,6,17189889
0,22.1,Corneal oedema,2,17189938
1,22.1,Hyperglycaemia,2,17189938
2,22.1,Rash,2,17189938
0,22.1,Granulocytopenia,2,17190012
0,22.1,Dyspnoea,3,17190087
1,22.1,General physical health deterioration,3,17190087
2,22.1,Cough,3,17190087
3,22.1,Pyrexia,6,17190087
4,22.1,Pneumonia,3,17190087
5,22.1,Decreased appetite,6,17190087
0,22.1,Product use complaint,6,17190151
1,22.1,Foreign body in respiratory tract,2,17190151
2,22.1,Product physical issue,6,17190151
3,22.1,Regurgitation,6,17190151
4,22.1,Foreign body aspiration,2,17190151
5,22.1,Aphonia,2,17190151
0,22.1,Jaundice,6,17190165
1,22.1,Faeces discoloured,6,17190165
2,22.1,Pruritus,6,17190165
3,22.1,Drug-induced liver injury,2,17190165
4,22.1,Abdominal pain,6,17190165
5,22.1,Chromaturia,6,17190165
0,22.1,Fatigue,3,17190171
1,22.1,Pain,3,17190171
2,22.1,Adverse reaction,3,17190171
3,22.1,Monoplegia,3,17190171
4,22.1,Dyspnoea,3,17190171
0,22.1,Liver disorder,2,17190173
1,22.1,Transaminases increased,2,17190173
2,22.1,Blood bilirubin increased,2,17190173
0,22.1,Renal failure,2,17190174
1,22.1,Vomiting,2,17190174
2,22.1,Pain,2,17190174
3,22.1,Nausea,2,17190174
0,22.1,Delirium,6,17190274
1,22.1,Hyponatraemia,6,17190274
2,22.1,Leukopenia,6,17190274
3,22.1,Death,5,17190274
4,22.1,Hypokalaemia,6,17190274
5,22.1,Dermatitis,6,17190274
6,22.1,Paraparesis,6,17190274
7,22.1,Inappropriate antidiuretic hormone secretion,6,17190274
8,22.1,Fatigue,6,17190274
9,22.1,Malignant neoplasm progression,6,17190274
10,22.1,Metastases to meninges,6,17190274
0,22.1,Diverticular perforation,2,17190300
1,22.1,Peritonitis,2,17190300
0,22.1,Asthenia,3,17190324
0,22.1,Intentional product use issue,6,17190360
1,22.1,Death,5,17190360
0,22.1,Malignant neoplasm progression,5,17190364
0,22.1,Perineal abscess,1,17190365
1,22.1,Incarcerated inguinal hernia,1,17190365
0,22.1,Death,5,17190368
0,22.1,Cough,6,17190383
1,22.1,Dyspnoea,6,17190383
2,22.1,Agranulocytosis,6,17190383
0,22.1,Aortic thrombosis,6,17190401
0,22.1,Febrile neutropenia,5,17190523
0,22.1,Cardiotoxicity,4,17190531
1,22.1,Hypertension,6,17190531
0,22.1,Death,5,17190539
0,22.1,Myocardial infarction,6,17190541
1,22.1,Pain,6,17190541
2,22.1,Diarrhoea,6,17190541
3,22.1,Hypertension,6,17190541
4,22.1,Constipation,6,17190541
5,22.1,Weight decreased,6,17190541
6,22.1,Gait disturbance,6,17190541
0,22.1,Cold sweat,6,17190547
1,22.1,Feeding disorder,6,17190547
2,22.1,Nephropathy toxic,6,17190547
3,22.1,Blood pressure increased,6,17190547
4,22.1,Dehydration,6,17190547
0,22.1,Febrile neutropenia,1,17190645
0,22.1,Skin neoplasm excision,,17190650
1,22.1,Therapy change,,17190650
0,22.1,Arthritis infective,6,17190667
0,22.1,Malignant neoplasm progression,3,17190724
0,22.1,Drug interaction,6,17190730
1,22.1,Aortic dissection,1,17190730
2,22.1,Hypertension,1,17190730
0,22.1,Anaemia,1,17190760
1,22.1,Overdose,1,17190760
0,22.1,Product use in unapproved indication,6,17190761
1,22.1,Feeling abnormal,6,17190761
2,22.1,Liver function test abnormal,5,17190761
3,22.1,Oedema peripheral,6,17190761
0,22.1,Lymphocyte percentage decreased,1,17190787
1,22.1,Neutrophil percentage decreased,1,17190787
2,22.1,White blood cell count decreased,1,17190787
0,22.1,Hypotension,1,17190796
1,22.1,Pruritus,1,17190796
2,22.1,Rash,1,17190796
3,22.1,Visual impairment,1,17190796
4,22.1,Oxygen saturation decreased,1,17190796
0,22.1,Diarrhoea,,17190801
0,22.1,Type 2 diabetes mellitus,1,17190824
0,22.1,Product use in unapproved indication,6,17190830
1,22.1,Drug ineffective,6,17190830
0,22.1,Facial paresis,1,17190836
1,22.1,Pupils unequal,1,17190836
2,22.1,Insomnia,1,17190836
3,22.1,Pruritus,3,17190836
4,22.1,Weight decreased,1,17190836
5,22.1,Diabetes mellitus inadequate control,4,17190836
6,22.1,Herpes simplex,1,17190836
7,22.1,Perioral dermatitis,1,17190836
8,22.1,Cough,3,17190836
9,22.1,Fatigue,3,17190836
0,22.1,Bone marrow failure,2,17190847
0,22.1,Colon cancer,,17190854
1,22.1,Hepatic cancer,,17190854
0,22.1,Hepatitis E,1,17190856
0,22.1,Thrombosis,3,17190857
1,22.1,Upper respiratory tract infection,1,17190857
2,22.1,White blood cell count decreased,1,17190857
3,22.1,Bronchitis,1,17190857
0,22.1,Photosensitivity reaction,3,17190861
0,22.1,Malignant neoplasm progression,5,17190872
0,22.1,Product odour abnormal,,17190995
1,22.1,Feeling abnormal,,17190995
2,22.1,Pruritus,,17190995
3,22.1,Abdominal pain upper,,17190995
4,22.1,Headache,,17190995
0,22.1,Neuropathy peripheral,4,17190996
1,22.1,Neoplasm progression,4,17190996
0,22.1,Osteoradionecrosis,1,17191001
1,22.1,Oropharyngeal scar,6,17191001
2,22.1,Soft tissue infection,1,17191001
3,22.1,Sepsis,1,17191001
4,22.1,Pharyngeal ulceration,1,17191001
5,22.1,Fistula,1,17191001
6,22.1,Pharyngeal disorder,3,17191001
7,22.1,Septic shock,1,17191001
8,22.1,Laryngeal oedema,3,17191001
9,22.1,Nasal ulcer,1,17191001
10,22.1,Necrotising fasciitis,1,17191001
11,22.1,Trismus,6,17191001
12,22.1,Pharyngeal oedema,1,17191001
0,22.1,Death,,17191029
0,22.1,Nausea,,17191046
1,22.1,Fatigue,,17191046
0,22.1,Ovarian neoplasm,6,17191060
1,22.1,Breast cancer metastatic,6,17191060
2,22.1,Hepatic necrosis,6,17191060
3,22.1,Ascites,1,17191060
4,22.1,Metastases to liver,2,17191060
5,22.1,Malignant neoplasm progression,6,17191060
6,22.1,Bone disorder,6,17191060
0,22.1,Hypertension,6,17191065
0,22.1,Myopathy,2,17191074
1,22.1,Myalgia,2,17191074
2,22.1,Drug interaction,6,17191074
3,22.1,Rhabdomyolysis,2,17191074
4,22.1,Toxicity to various agents,2,17191074
0,22.1,Liver injury,6,17191187
0,22.1,Polyneuropathy,3,17191201
1,22.1,Anaemia,6,17191201
